nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Nateglinide—type 2 diabetes mellitus	0.485	1	CrCtD
Dextroamphetamine—Aspartame—Nateglinide—type 2 diabetes mellitus	0.0465	0.175	CrCrCtD
Dextroamphetamine—Lacosamide—Nateglinide—type 2 diabetes mellitus	0.0465	0.175	CrCrCtD
Dextroamphetamine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0363	0.318	CbGbCtD
Dextroamphetamine—Phenacemide—Nateglinide—type 2 diabetes mellitus	0.0315	0.118	CrCrCtD
Dextroamphetamine—Amphetamine—Nateglinide—type 2 diabetes mellitus	0.0306	0.115	CrCrCtD
Dextroamphetamine—Nateglinide—Ramipril—type 2 diabetes mellitus	0.0298	0.112	CrCrCtD
Dextroamphetamine—Methamphetamine—Nateglinide—type 2 diabetes mellitus	0.0297	0.112	CrCrCtD
Dextroamphetamine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0287	0.251	CbGbCtD
Dextroamphetamine—Aspartame—Ramipril—type 2 diabetes mellitus	0.0283	0.106	CrCrCtD
Dextroamphetamine—L-Phenylalanine—Nateglinide—type 2 diabetes mellitus	0.0233	0.0874	CrCrCtD
Dextroamphetamine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0145	0.127	CbGbCtD
Dextroamphetamine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0134	0.117	CbGbCtD
Dextroamphetamine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.011	0.0959	CbGbCtD
Dextroamphetamine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0105	0.092	CbGbCtD
Dextroamphetamine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00077	0.287	CbGeAlD
Dextroamphetamine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.000518	0.193	CbGeAlD
Dextroamphetamine—Phenformin—PRKAA1—type 2 diabetes mellitus	0.000468	0.188	CrCbGaD
Dextroamphetamine—Amphetamine—CARTPT—type 2 diabetes mellitus	0.000364	0.147	CrCbGaD
Dextroamphetamine—SLC6A3—nerve—type 2 diabetes mellitus	0.000361	0.135	CbGeAlD
Dextroamphetamine—Phenelzine—AOC3—type 2 diabetes mellitus	0.000292	0.118	CrCbGaD
Dextroamphetamine—SLC6A2—nerve—type 2 diabetes mellitus	0.000291	0.109	CbGeAlD
Dextroamphetamine—ADRA1B—kidney—type 2 diabetes mellitus	0.000165	0.0616	CbGeAlD
Dextroamphetamine—Nateglinide—ABCC8—type 2 diabetes mellitus	0.000156	0.0628	CrCbGaD
Dextroamphetamine—SLC18A2—adipose tissue—type 2 diabetes mellitus	0.000147	0.0549	CbGeAlD
Dextroamphetamine—Nateglinide—KCNJ11—type 2 diabetes mellitus	0.00011	0.0442	CrCbGaD
Dextroamphetamine—SLC18A2—liver—type 2 diabetes mellitus	0.000103	0.0385	CbGeAlD
Dextroamphetamine—Decreased appetite—Glyburide—type 2 diabetes mellitus	9.59e-05	0.00114	CcSEcCtD
Dextroamphetamine—Urticaria—Bromocriptine—type 2 diabetes mellitus	9.59e-05	0.00114	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	9.58e-05	0.00113	CcSEcCtD
Dextroamphetamine—Asthenia—Sitagliptin—type 2 diabetes mellitus	9.57e-05	0.00113	CcSEcCtD
Dextroamphetamine—Convulsion—Orlistat—type 2 diabetes mellitus	9.55e-05	0.00113	CcSEcCtD
Dextroamphetamine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	9.54e-05	0.00113	CcSEcCtD
Dextroamphetamine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	9.54e-05	0.00113	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	9.53e-05	0.00113	CcSEcCtD
Dextroamphetamine—Tremor—Metformin—type 2 diabetes mellitus	9.52e-05	0.00113	CcSEcCtD
Dextroamphetamine—Chest pain—Valsartan—type 2 diabetes mellitus	9.5e-05	0.00112	CcSEcCtD
Dextroamphetamine—Sweating—Ramipril—type 2 diabetes mellitus	9.49e-05	0.00112	CcSEcCtD
Dextroamphetamine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	9.49e-05	0.0353	CbGeAlD
Dextroamphetamine—Dizziness—Glipizide—type 2 diabetes mellitus	9.48e-05	0.00112	CcSEcCtD
Dextroamphetamine—Anxiety—Valsartan—type 2 diabetes mellitus	9.47e-05	0.00112	CcSEcCtD
Dextroamphetamine—Tension—Irbesartan—type 2 diabetes mellitus	9.41e-05	0.00111	CcSEcCtD
Dextroamphetamine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	9.4e-05	0.00111	CcSEcCtD
Dextroamphetamine—Chest pain—Orlistat—type 2 diabetes mellitus	9.39e-05	0.00111	CcSEcCtD
Dextroamphetamine—Anxiety—Orlistat—type 2 diabetes mellitus	9.35e-05	0.00111	CcSEcCtD
Dextroamphetamine—Nervousness—Irbesartan—type 2 diabetes mellitus	9.31e-05	0.0011	CcSEcCtD
Dextroamphetamine—Dry mouth—Valsartan—type 2 diabetes mellitus	9.29e-05	0.0011	CcSEcCtD
Dextroamphetamine—Dry mouth—Orlistat—type 2 diabetes mellitus	9.18e-05	0.00109	CcSEcCtD
Dextroamphetamine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	9.16e-05	0.00108	CcSEcCtD
Dextroamphetamine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	9.13e-05	0.00108	CcSEcCtD
Dextroamphetamine—Vomiting—Glipizide—type 2 diabetes mellitus	9.12e-05	0.00108	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	9.11e-05	0.00108	CcSEcCtD
Dextroamphetamine—Dizziness—Pioglitazone—type 2 diabetes mellitus	9.08e-05	0.00108	CcSEcCtD
Dextroamphetamine—Infection—Valsartan—type 2 diabetes mellitus	9.05e-05	0.00107	CcSEcCtD
Dextroamphetamine—Rash—Glipizide—type 2 diabetes mellitus	9.04e-05	0.00107	CcSEcCtD
Dextroamphetamine—Dermatitis—Glipizide—type 2 diabetes mellitus	9.03e-05	0.00107	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	9.02e-05	0.00107	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	9e-05	0.00106	CcSEcCtD
Dextroamphetamine—Headache—Glipizide—type 2 diabetes mellitus	8.98e-05	0.00106	CcSEcCtD
Dextroamphetamine—Tremor—Irbesartan—type 2 diabetes mellitus	8.98e-05	0.00106	CcSEcCtD
Dextroamphetamine—Palpitations—Metformin—type 2 diabetes mellitus	8.98e-05	0.00106	CcSEcCtD
Dextroamphetamine—Insomnia—Gliclazide—type 2 diabetes mellitus	8.96e-05	0.00106	CcSEcCtD
Dextroamphetamine—Infection—Orlistat—type 2 diabetes mellitus	8.94e-05	0.00106	CcSEcCtD
Dextroamphetamine—Tolazoline—ADRA2A—type 2 diabetes mellitus	8.86e-05	0.0357	CrCbGaD
Dextroamphetamine—Tension—Losartan—type 2 diabetes mellitus	8.85e-05	0.00105	CcSEcCtD
Dextroamphetamine—Dizziness—Glimepiride—type 2 diabetes mellitus	8.85e-05	0.00105	CcSEcCtD
Dextroamphetamine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	8.84e-05	0.00105	CcSEcCtD
Dextroamphetamine—Dizziness—Sitagliptin—type 2 diabetes mellitus	8.82e-05	0.00104	CcSEcCtD
Dextroamphetamine—Agitation—Irbesartan—type 2 diabetes mellitus	8.81e-05	0.00104	CcSEcCtD
Dextroamphetamine—Somnolence—Gliclazide—type 2 diabetes mellitus	8.81e-05	0.00104	CcSEcCtD
Dextroamphetamine—Hypertension—Metformin—type 2 diabetes mellitus	8.77e-05	0.00104	CcSEcCtD
Dextroamphetamine—Urticaria—Glyburide—type 2 diabetes mellitus	8.77e-05	0.00104	CcSEcCtD
Dextroamphetamine—Nervousness—Losartan—type 2 diabetes mellitus	8.76e-05	0.00104	CcSEcCtD
Dextroamphetamine—Angioedema—Irbesartan—type 2 diabetes mellitus	8.76e-05	0.00104	CcSEcCtD
Dextroamphetamine—Abdominal pain—Glyburide—type 2 diabetes mellitus	8.72e-05	0.00103	CcSEcCtD
Dextroamphetamine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	8.72e-05	0.00103	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	8.7e-05	0.00103	CcSEcCtD
Dextroamphetamine—Anorexia—Valsartan—type 2 diabetes mellitus	8.68e-05	0.00103	CcSEcCtD
Dextroamphetamine—Asthenia—Bromocriptine—type 2 diabetes mellitus	8.66e-05	0.00103	CcSEcCtD
Dextroamphetamine—Chest pain—Metformin—type 2 diabetes mellitus	8.65e-05	0.00102	CcSEcCtD
Dextroamphetamine—Headache—Pioglitazone—type 2 diabetes mellitus	8.61e-05	0.00102	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	8.56e-05	0.00101	CcSEcCtD
Dextroamphetamine—Fatigue—Gliclazide—type 2 diabetes mellitus	8.54e-05	0.00101	CcSEcCtD
Dextroamphetamine—Nausea—Glipizide—type 2 diabetes mellitus	8.52e-05	0.00101	CcSEcCtD
Dextroamphetamine—Vomiting—Glimepiride—type 2 diabetes mellitus	8.51e-05	0.00101	CcSEcCtD
Dextroamphetamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.48e-05	0.001	CcSEcCtD
Dextroamphetamine—Constipation—Gliclazide—type 2 diabetes mellitus	8.47e-05	0.001	CcSEcCtD
Dextroamphetamine—Tremor—Losartan—type 2 diabetes mellitus	8.45e-05	0.001	CcSEcCtD
Dextroamphetamine—Rash—Glimepiride—type 2 diabetes mellitus	8.44e-05	0.000999	CcSEcCtD
Dextroamphetamine—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.43e-05	0.000998	CcSEcCtD
Dextroamphetamine—Rash—Sitagliptin—type 2 diabetes mellitus	8.41e-05	0.000995	CcSEcCtD
Dextroamphetamine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.4e-05	0.000994	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000994	CcSEcCtD
Dextroamphetamine—Headache—Glimepiride—type 2 diabetes mellitus	8.38e-05	0.000992	CcSEcCtD
Dextroamphetamine—ADRA1A—adipose tissue—type 2 diabetes mellitus	8.37e-05	0.0312	CbGeAlD
Dextroamphetamine—Headache—Sitagliptin—type 2 diabetes mellitus	8.36e-05	0.000989	CcSEcCtD
Dextroamphetamine—Agitation—Losartan—type 2 diabetes mellitus	8.29e-05	0.000981	CcSEcCtD
Dextroamphetamine—Hypertension—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.00098	CcSEcCtD
Dextroamphetamine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.26e-05	0.000978	CcSEcCtD
Dextroamphetamine—Angioedema—Losartan—type 2 diabetes mellitus	8.24e-05	0.000976	CcSEcCtD
Dextroamphetamine—Infection—Metformin—type 2 diabetes mellitus	8.24e-05	0.000975	CcSEcCtD
Dextroamphetamine—Insomnia—Valsartan—type 2 diabetes mellitus	8.24e-05	0.000975	CcSEcCtD
Dextroamphetamine—Chest pain—Irbesartan—type 2 diabetes mellitus	8.16e-05	0.000966	CcSEcCtD
Dextroamphetamine—Insomnia—Orlistat—type 2 diabetes mellitus	8.14e-05	0.000963	CcSEcCtD
Dextroamphetamine—Anxiety—Irbesartan—type 2 diabetes mellitus	8.13e-05	0.000963	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.13e-05	0.000962	CcSEcCtD
Dextroamphetamine—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.12e-05	0.000961	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.1e-05	0.000959	CcSEcCtD
Dextroamphetamine—Somnolence—Valsartan—type 2 diabetes mellitus	8.09e-05	0.000958	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.02e-05	0.000949	CcSEcCtD
Dextroamphetamine—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.01e-05	0.000948	CcSEcCtD
Dextroamphetamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.98e-05	0.000945	CcSEcCtD
Dextroamphetamine—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.98e-05	0.000945	CcSEcCtD
Dextroamphetamine—Palpitations—Losartan—type 2 diabetes mellitus	7.97e-05	0.000944	CcSEcCtD
Dextroamphetamine—Nausea—Glimepiride—type 2 diabetes mellitus	7.95e-05	0.000941	CcSEcCtD
Dextroamphetamine—Nausea—Sitagliptin—type 2 diabetes mellitus	7.92e-05	0.000938	CcSEcCtD
Dextroamphetamine—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.92e-05	0.000937	CcSEcCtD
Dextroamphetamine—Asthenia—Glyburide—type 2 diabetes mellitus	7.92e-05	0.000937	CcSEcCtD
Dextroamphetamine—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.91e-05	0.000937	CcSEcCtD
Dextroamphetamine—Anorexia—Metformin—type 2 diabetes mellitus	7.9e-05	0.000935	CcSEcCtD
Dextroamphetamine—Urticaria—Gliclazide—type 2 diabetes mellitus	7.87e-05	0.000932	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.86e-05	0.00093	CcSEcCtD
Dextroamphetamine—Fatigue—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000929	CcSEcCtD
Dextroamphetamine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.000927	CcSEcCtD
Dextroamphetamine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.000927	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.82e-05	0.000926	CcSEcCtD
Dextroamphetamine—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.82e-05	0.000926	CcSEcCtD
Dextroamphetamine—Constipation—Valsartan—type 2 diabetes mellitus	7.79e-05	0.000921	CcSEcCtD
Dextroamphetamine—Infection—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.00092	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.77e-05	0.000919	CcSEcCtD
Dextroamphetamine—Fatigue—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000918	CcSEcCtD
Dextroamphetamine—Phenylpropanolamine—ADRA2A—type 2 diabetes mellitus	7.74e-05	0.0312	CrCbGaD
Dextroamphetamine—Chest pain—Losartan—type 2 diabetes mellitus	7.68e-05	0.000909	CcSEcCtD
Dextroamphetamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.68e-05	0.000908	CcSEcCtD
Dextroamphetamine—Anxiety—Losartan—type 2 diabetes mellitus	7.66e-05	0.000906	CcSEcCtD
Dextroamphetamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000904	CcSEcCtD
Dextroamphetamine—Rash—Bromocriptine—type 2 diabetes mellitus	7.61e-05	0.000901	CcSEcCtD
Dextroamphetamine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.61e-05	0.0009	CcSEcCtD
Dextroamphetamine—Tension—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000898	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.56e-05	0.000895	CcSEcCtD
Dextroamphetamine—Headache—Bromocriptine—type 2 diabetes mellitus	7.56e-05	0.000895	CcSEcCtD
Dextroamphetamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.55e-05	0.000894	CcSEcCtD
Dextroamphetamine—Nervousness—Ramipril—type 2 diabetes mellitus	7.51e-05	0.000889	CcSEcCtD
Dextroamphetamine—Dry mouth—Losartan—type 2 diabetes mellitus	7.51e-05	0.000889	CcSEcCtD
Dextroamphetamine—Anorexia—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000883	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.45e-05	0.000881	CcSEcCtD
Dextroamphetamine—Dyspnoea—Metformin—type 2 diabetes mellitus	7.39e-05	0.000875	CcSEcCtD
Dextroamphetamine—Somnolence—Metformin—type 2 diabetes mellitus	7.37e-05	0.000872	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.36e-05	0.000871	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.36e-05	0.000871	CcSEcCtD
Dextroamphetamine—Infection—Losartan—type 2 diabetes mellitus	7.32e-05	0.000866	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.3e-05	0.000864	CcSEcCtD
Dextroamphetamine—Dyspepsia—Metformin—type 2 diabetes mellitus	7.3e-05	0.000864	CcSEcCtD
Dextroamphetamine—Tremor—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000858	CcSEcCtD
Dextroamphetamine—Urticaria—Valsartan—type 2 diabetes mellitus	7.23e-05	0.000856	CcSEcCtD
Dextroamphetamine—Decreased appetite—Metformin—type 2 diabetes mellitus	7.21e-05	0.000853	CcSEcCtD
Dextroamphetamine—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.2e-05	0.000852	CcSEcCtD
Dextroamphetamine—Tachycardia—Losartan—type 2 diabetes mellitus	7.19e-05	0.000851	CcSEcCtD
Dextroamphetamine—Nausea—Bromocriptine—type 2 diabetes mellitus	7.17e-05	0.000849	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.16e-05	0.000847	CcSEcCtD
Dextroamphetamine—Fatigue—Metformin—type 2 diabetes mellitus	7.15e-05	0.000846	CcSEcCtD
Dextroamphetamine—Urticaria—Orlistat—type 2 diabetes mellitus	7.15e-05	0.000846	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.12e-05	0.000842	CcSEcCtD
Dextroamphetamine—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000842	CcSEcCtD
Dextroamphetamine—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000842	CcSEcCtD
Dextroamphetamine—Asthenia—Gliclazide—type 2 diabetes mellitus	7.11e-05	0.000841	CcSEcCtD
Dextroamphetamine—Agitation—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000841	CcSEcCtD
Dextroamphetamine—Constipation—Metformin—type 2 diabetes mellitus	7.09e-05	0.000839	CcSEcCtD
Dextroamphetamine—Angioedema—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000837	CcSEcCtD
Dextroamphetamine—Anorexia—Losartan—type 2 diabetes mellitus	7.02e-05	0.000831	CcSEcCtD
Dextroamphetamine—Vomiting—Glyburide—type 2 diabetes mellitus	7.02e-05	0.00083	CcSEcCtD
Dextroamphetamine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000826	CcSEcCtD
Dextroamphetamine—Rash—Glyburide—type 2 diabetes mellitus	6.96e-05	0.000824	CcSEcCtD
Dextroamphetamine—Somnolence—Irbesartan—type 2 diabetes mellitus	6.96e-05	0.000823	CcSEcCtD
Dextroamphetamine—Dermatitis—Glyburide—type 2 diabetes mellitus	6.95e-05	0.000823	CcSEcCtD
Dextroamphetamine—Headache—Glyburide—type 2 diabetes mellitus	6.91e-05	0.000818	CcSEcCtD
Dextroamphetamine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.000815	CcSEcCtD
Dextroamphetamine—Palpitations—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000809	CcSEcCtD
Dextroamphetamine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000805	CcSEcCtD
Dextroamphetamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.78e-05	0.000802	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.78e-05	0.000802	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.76e-05	0.000799	CcSEcCtD
Dextroamphetamine—Fatigue—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000798	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.71e-05	0.000794	CcSEcCtD
Dextroamphetamine—Convulsion—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000793	CcSEcCtD
Dextroamphetamine—Constipation—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000792	CcSEcCtD
Dextroamphetamine—Insomnia—Losartan—type 2 diabetes mellitus	6.66e-05	0.000788	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.63e-05	0.000784	CcSEcCtD
Dextroamphetamine—Urticaria—Metformin—type 2 diabetes mellitus	6.59e-05	0.00078	CcSEcCtD
Dextroamphetamine—Chest pain—Ramipril—type 2 diabetes mellitus	6.59e-05	0.000779	CcSEcCtD
Dextroamphetamine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.57e-05	0.000777	CcSEcCtD
Dextroamphetamine—Anxiety—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000777	CcSEcCtD
Dextroamphetamine—Nausea—Glyburide—type 2 diabetes mellitus	6.56e-05	0.000776	CcSEcCtD
Dextroamphetamine—Abdominal pain—Metformin—type 2 diabetes mellitus	6.55e-05	0.000776	CcSEcCtD
Dextroamphetamine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.55e-05	0.000776	CcSEcCtD
Dextroamphetamine—Somnolence—Losartan—type 2 diabetes mellitus	6.55e-05	0.000775	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—ADRA2A—type 2 diabetes mellitus	6.54e-05	0.0263	CrCbGaD
Dextroamphetamine—Asthenia—Valsartan—type 2 diabetes mellitus	6.53e-05	0.000773	CcSEcCtD
Dextroamphetamine—Dyspepsia—Losartan—type 2 diabetes mellitus	6.48e-05	0.000767	CcSEcCtD
Dextroamphetamine—Asthenia—Orlistat—type 2 diabetes mellitus	6.46e-05	0.000764	CcSEcCtD
Dextroamphetamine—Dry mouth—Ramipril—type 2 diabetes mellitus	6.44e-05	0.000762	CcSEcCtD
Dextroamphetamine—Decreased appetite—Losartan—type 2 diabetes mellitus	6.4e-05	0.000758	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.4e-05	0.000757	CcSEcCtD
Dextroamphetamine—Fatigue—Losartan—type 2 diabetes mellitus	6.35e-05	0.000751	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000747	CcSEcCtD
Dextroamphetamine—Vomiting—Gliclazide—type 2 diabetes mellitus	6.3e-05	0.000746	CcSEcCtD
Dextroamphetamine—Constipation—Losartan—type 2 diabetes mellitus	6.3e-05	0.000745	CcSEcCtD
Dextroamphetamine—Rash—Gliclazide—type 2 diabetes mellitus	6.25e-05	0.000739	CcSEcCtD
Dextroamphetamine—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.24e-05	0.000739	CcSEcCtD
Dextroamphetamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000737	CcSEcCtD
Dextroamphetamine—Urticaria—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000736	CcSEcCtD
Dextroamphetamine—Headache—Gliclazide—type 2 diabetes mellitus	6.21e-05	0.000735	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—TNF—type 2 diabetes mellitus	6.2e-05	0.025	CrCbGaD
Dextroamphetamine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000732	CcSEcCtD
Dextroamphetamine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000732	CcSEcCtD
Dextroamphetamine—Tachycardia—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000729	CcSEcCtD
Dextroamphetamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.16e-05	0.000728	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000722	CcSEcCtD
Dextroamphetamine—Nateglinide—PPARG—type 2 diabetes mellitus	6.09e-05	0.0245	CrCbGaD
Dextroamphetamine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.02e-05	0.000713	CcSEcCtD
Dextroamphetamine—Dizziness—Valsartan—type 2 diabetes mellitus	6.02e-05	0.000713	CcSEcCtD
Dextroamphetamine—Anorexia—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000712	CcSEcCtD
Dextroamphetamine—Tranylcypromine—CYP2E1—type 2 diabetes mellitus	6.01e-05	0.0242	CrCbGaD
Dextroamphetamine—Dizziness—Orlistat—type 2 diabetes mellitus	5.95e-05	0.000704	CcSEcCtD
Dextroamphetamine—Asthenia—Metformin—type 2 diabetes mellitus	5.95e-05	0.000704	CcSEcCtD
Dextroamphetamine—Nausea—Gliclazide—type 2 diabetes mellitus	5.89e-05	0.000697	CcSEcCtD
Dextroamphetamine—ADRA1A—liver—type 2 diabetes mellitus	5.87e-05	0.0219	CbGeAlD
Dextroamphetamine—Urticaria—Losartan—type 2 diabetes mellitus	5.85e-05	0.000692	CcSEcCtD
Dextroamphetamine—Abdominal pain—Losartan—type 2 diabetes mellitus	5.82e-05	0.000689	CcSEcCtD
Dextroamphetamine—Body temperature increased—Losartan—type 2 diabetes mellitus	5.82e-05	0.000689	CcSEcCtD
Dextroamphetamine—Vomiting—Valsartan—type 2 diabetes mellitus	5.79e-05	0.000685	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.76e-05	0.000682	CcSEcCtD
Dextroamphetamine—Rash—Valsartan—type 2 diabetes mellitus	5.74e-05	0.000679	CcSEcCtD
Dextroamphetamine—Dermatitis—Valsartan—type 2 diabetes mellitus	5.74e-05	0.000679	CcSEcCtD
Dextroamphetamine—Vomiting—Orlistat—type 2 diabetes mellitus	5.72e-05	0.000677	CcSEcCtD
Dextroamphetamine—Tranylcypromine—CYP1A2—type 2 diabetes mellitus	5.72e-05	0.023	CrCbGaD
Dextroamphetamine—Insomnia—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000676	CcSEcCtD
Dextroamphetamine—Headache—Valsartan—type 2 diabetes mellitus	5.7e-05	0.000675	CcSEcCtD
Dextroamphetamine—Diarrhoea—Metformin—type 2 diabetes mellitus	5.67e-05	0.000671	CcSEcCtD
Dextroamphetamine—Rash—Orlistat—type 2 diabetes mellitus	5.67e-05	0.000671	CcSEcCtD
Dextroamphetamine—Dermatitis—Orlistat—type 2 diabetes mellitus	5.67e-05	0.000671	CcSEcCtD
Dextroamphetamine—Headache—Orlistat—type 2 diabetes mellitus	5.64e-05	0.000667	CcSEcCtD
Dextroamphetamine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000666	CcSEcCtD
Dextroamphetamine—Asthenia—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000664	CcSEcCtD
Dextroamphetamine—Somnolence—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000664	CcSEcCtD
Dextroamphetamine—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000658	CcSEcCtD
Dextroamphetamine—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.49e-05	0.00065	CcSEcCtD
Dextroamphetamine—Dizziness—Metformin—type 2 diabetes mellitus	5.48e-05	0.000649	CcSEcCtD
Dextroamphetamine—CYP2D6—kidney—type 2 diabetes mellitus	5.47e-05	0.0204	CbGeAlD
Dextroamphetamine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000645	CcSEcCtD
Dextroamphetamine—Fatigue—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000644	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.43e-05	0.000642	CcSEcCtD
Dextroamphetamine—Nausea—Valsartan—type 2 diabetes mellitus	5.41e-05	0.00064	CcSEcCtD
Dextroamphetamine—Constipation—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000639	CcSEcCtD
Dextroamphetamine—Phenylpropanolamine—CYP1A2—type 2 diabetes mellitus	5.38e-05	0.0216	CrCbGaD
Dextroamphetamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000634	CcSEcCtD
Dextroamphetamine—Nausea—Orlistat—type 2 diabetes mellitus	5.34e-05	0.000632	CcSEcCtD
Dextroamphetamine—Asthenia—Losartan—type 2 diabetes mellitus	5.28e-05	0.000625	CcSEcCtD
Dextroamphetamine—Vomiting—Metformin—type 2 diabetes mellitus	5.27e-05	0.000624	CcSEcCtD
Dextroamphetamine—Rash—Metformin—type 2 diabetes mellitus	5.23e-05	0.000619	CcSEcCtD
Dextroamphetamine—Dermatitis—Metformin—type 2 diabetes mellitus	5.22e-05	0.000618	CcSEcCtD
Dextroamphetamine—Headache—Metformin—type 2 diabetes mellitus	5.19e-05	0.000615	CcSEcCtD
Dextroamphetamine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.17e-05	0.000612	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000611	CcSEcCtD
Dextroamphetamine—Diarrhoea—Losartan—type 2 diabetes mellitus	5.04e-05	0.000596	CcSEcCtD
Dextroamphetamine—Urticaria—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000594	CcSEcCtD
Dextroamphetamine—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000591	CcSEcCtD
Dextroamphetamine—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000591	CcSEcCtD
Dextroamphetamine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000589	CcSEcCtD
Dextroamphetamine—Rash—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000584	CcSEcCtD
Dextroamphetamine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000583	CcSEcCtD
Dextroamphetamine—Nausea—Metformin—type 2 diabetes mellitus	4.93e-05	0.000583	CcSEcCtD
Dextroamphetamine—Methamphetamine—ADRA2A—type 2 diabetes mellitus	4.92e-05	0.0198	CrCbGaD
Dextroamphetamine—Headache—Irbesartan—type 2 diabetes mellitus	4.9e-05	0.00058	CcSEcCtD
Dextroamphetamine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	4.88e-05	0.0196	CrCbGaD
Dextroamphetamine—Dizziness—Losartan—type 2 diabetes mellitus	4.87e-05	0.000576	CcSEcCtD
Dextroamphetamine—Benzyl alcohol—CYP2E1—type 2 diabetes mellitus	4.86e-05	0.0196	CrCbGaD
Dextroamphetamine—Phentermine—CYP1A2—type 2 diabetes mellitus	4.79e-05	0.0193	CrCbGaD
Dextroamphetamine—Vomiting—Losartan—type 2 diabetes mellitus	4.68e-05	0.000554	CcSEcCtD
Dextroamphetamine—Selegiline—CYP2E1—type 2 diabetes mellitus	4.66e-05	0.0188	CrCbGaD
Dextroamphetamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000551	CcSEcCtD
Dextroamphetamine—Nausea—Irbesartan—type 2 diabetes mellitus	4.65e-05	0.00055	CcSEcCtD
Dextroamphetamine—Rash—Losartan—type 2 diabetes mellitus	4.64e-05	0.000549	CcSEcCtD
Dextroamphetamine—Dermatitis—Losartan—type 2 diabetes mellitus	4.64e-05	0.000549	CcSEcCtD
Dextroamphetamine—Benzyl alcohol—CYP1A2—type 2 diabetes mellitus	4.62e-05	0.0186	CrCbGaD
Dextroamphetamine—Headache—Losartan—type 2 diabetes mellitus	4.61e-05	0.000546	CcSEcCtD
Dextroamphetamine—Asthenia—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000536	CcSEcCtD
Dextroamphetamine—Selegiline—CYP1A2—type 2 diabetes mellitus	4.43e-05	0.0179	CrCbGaD
Dextroamphetamine—Nausea—Losartan—type 2 diabetes mellitus	4.37e-05	0.000518	CcSEcCtD
Dextroamphetamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000511	CcSEcCtD
Dextroamphetamine—Dizziness—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000494	CcSEcCtD
Dextroamphetamine—Phenelzine—CYP2E1—type 2 diabetes mellitus	4.11e-05	0.0165	CrCbGaD
Dextroamphetamine—Vomiting—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000475	CcSEcCtD
Dextroamphetamine—Rash—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000471	CcSEcCtD
Dextroamphetamine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000471	CcSEcCtD
Dextroamphetamine—Headache—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000468	CcSEcCtD
Dextroamphetamine—Tranylcypromine—CYP3A4—type 2 diabetes mellitus	3.79e-05	0.0152	CrCbGaD
Dextroamphetamine—Nausea—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000444	CcSEcCtD
Dextroamphetamine—CYP2D6—liver—type 2 diabetes mellitus	3.46e-05	0.0129	CbGeAlD
Dextroamphetamine—Benzyl alcohol—CYP3A4—type 2 diabetes mellitus	3.06e-05	0.0123	CrCbGaD
Dextroamphetamine—Selegiline—CYP3A4—type 2 diabetes mellitus	2.94e-05	0.0118	CrCbGaD
Dextroamphetamine—Nateglinide—CYP3A4—type 2 diabetes mellitus	2.62e-05	0.0106	CrCbGaD
Dextroamphetamine—Phenelzine—CYP3A4—type 2 diabetes mellitus	2.59e-05	0.0104	CrCbGaD
Dextroamphetamine—Nateglinide—ALB—type 2 diabetes mellitus	2.29e-05	0.00922	CrCbGaD
Dextroamphetamine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	2.24e-05	0.00903	CrCbGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.36e-06	0.000142	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.36e-06	0.000142	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	6.35e-06	0.000142	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	6.34e-06	0.000142	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.33e-06	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	6.3e-06	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.27e-06	0.00014	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	6.22e-06	0.000139	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.2e-06	0.000139	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	6.07e-06	0.000136	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	6.07e-06	0.000136	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	6.07e-06	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.05e-06	0.000135	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	5.95e-06	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	5.92e-06	0.000132	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	5.86e-06	0.000131	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—C3—type 2 diabetes mellitus	5.82e-06	0.00013	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	5.82e-06	0.00013	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	5.82e-06	0.00013	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	5.81e-06	0.00013	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	5.81e-06	0.00013	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.74e-06	0.000128	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	5.72e-06	0.000128	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.69e-06	0.000127	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.68e-06	0.000127	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	5.66e-06	0.000127	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	5.66e-06	0.000127	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AVP—type 2 diabetes mellitus	5.65e-06	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	5.65e-06	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.64e-06	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	5.64e-06	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	5.62e-06	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—INSR—type 2 diabetes mellitus	5.61e-06	0.000125	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	5.6e-06	0.000125	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	5.6e-06	0.000125	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.58e-06	0.000125	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	5.57e-06	0.000124	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.53e-06	0.000124	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.51e-06	0.000123	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	5.51e-06	0.000123	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	5.5e-06	0.000123	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.48e-06	0.000122	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	5.41e-06	0.000121	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	5.41e-06	0.000121	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	5.41e-06	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.41e-06	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	5.37e-06	0.00012	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	5.29e-06	0.000118	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—C3—type 2 diabetes mellitus	5.28e-06	0.000118	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.25e-06	0.000117	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	5.17e-06	0.000116	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.11e-06	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.1e-06	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.09e-06	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.09e-06	0.000114	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	5.08e-06	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.05e-06	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.02e-06	0.000112	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.01e-06	0.000112	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—INSR—type 2 diabetes mellitus	4.98e-06	0.000111	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.96e-06	0.000111	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.94e-06	0.00011	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.93e-06	0.00011	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	4.91e-06	0.00011	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	4.9e-06	0.000109	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	4.89e-06	0.000109	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	4.87e-06	0.000109	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.85e-06	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.83e-06	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.83e-06	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	4.8e-06	0.000107	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.77e-06	0.000107	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	4.76e-06	0.000106	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—C3—type 2 diabetes mellitus	4.69e-06	0.000105	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.66e-06	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.64e-06	0.000104	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	4.6e-06	0.000103	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	4.6e-06	0.000103	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	4.6e-06	0.000103	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	4.6e-06	0.000103	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.54e-06	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.53e-06	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.53e-06	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.49e-06	0.0001	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.47e-06	0.0001	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.46e-06	9.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GCG—type 2 diabetes mellitus	4.42e-06	9.87e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.42e-06	9.87e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	4.41e-06	9.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.4e-06	9.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.38e-06	9.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.38e-06	9.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.35e-06	9.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.33e-06	9.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.31e-06	9.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.29e-06	9.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.29e-06	9.59e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.29e-06	9.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.24e-06	9.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.13e-06	9.24e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.12e-06	9.21e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	4.1e-06	9.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.06e-06	9.08e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.06e-06	9.07e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.99e-06	8.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.97e-06	8.88e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.96e-06	8.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	3.92e-06	8.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.92e-06	8.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.86e-06	8.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.85e-06	8.6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.84e-06	8.59e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	3.83e-06	8.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.81e-06	8.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AVP—type 2 diabetes mellitus	3.76e-06	8.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.76e-06	8.4e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	3.75e-06	8.38e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	3.75e-06	8.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.74e-06	8.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.72e-06	8.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.68e-06	8.24e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	3.68e-06	8.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.67e-06	8.21e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	3.65e-06	8.17e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	3.65e-06	8.17e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	3.65e-06	8.17e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	3.63e-06	8.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOB—type 2 diabetes mellitus	3.63e-06	8.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.62e-06	8.08e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.61e-06	8.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.6e-06	8.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.57e-06	7.99e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	3.57e-06	7.97e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	3.52e-06	7.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LPL—type 2 diabetes mellitus	3.47e-06	7.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.41e-06	7.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.39e-06	7.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.38e-06	7.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	3.34e-06	7.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.34e-06	7.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.32e-06	7.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.31e-06	7.39e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	3.28e-06	7.32e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	3.28e-06	7.32e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	3.28e-06	7.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.27e-06	7.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.25e-06	7.27e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	3.22e-06	7.21e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.22e-06	7.19e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.21e-06	7.18e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.19e-06	7.14e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.19e-06	7.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.17e-06	7.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—C3—type 2 diabetes mellitus	3.12e-06	6.98e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.12e-06	6.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	3.08e-06	6.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.01e-06	6.74e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3e-06	6.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.98e-06	6.65e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.97e-06	6.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AGT—type 2 diabetes mellitus	2.97e-06	6.63e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	2.96e-06	6.62e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	2.96e-06	6.62e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.92e-06	6.52e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LEP—type 2 diabetes mellitus	2.91e-06	6.49e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOE—type 2 diabetes mellitus	2.91e-06	6.49e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.89e-06	6.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.89e-06	6.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.87e-06	6.42e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.84e-06	6.35e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.84e-06	6.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.84e-06	6.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	2.77e-06	6.2e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.74e-06	6.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.64e-06	5.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.64e-06	5.9e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	2.63e-06	5.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.59e-06	5.79e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.59e-06	5.79e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.58e-06	5.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.58e-06	5.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.55e-06	5.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	2.48e-06	5.55e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.45e-06	5.47e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.45e-06	5.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.44e-06	5.46e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.44e-06	5.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.43e-06	5.44e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.4e-06	5.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.4e-06	5.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.4e-06	5.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.39e-06	5.34e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.33e-06	5.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.3e-06	5.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.28e-06	5.1e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.27e-06	5.08e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.23e-06	4.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.2e-06	4.93e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.18e-06	4.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.18e-06	4.87e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.18e-06	4.87e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.17e-06	4.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.17e-06	4.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.13e-06	4.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.13e-06	4.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.12e-06	4.74e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.12e-06	4.73e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.09e-06	4.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.05e-06	4.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.03e-06	4.53e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.01e-06	4.49e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.97e-06	4.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.93e-06	4.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.93e-06	4.32e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.91e-06	4.26e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.88e-06	4.19e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.87e-06	4.18e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.87e-06	4.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.85e-06	4.13e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.85e-06	4.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.84e-06	4.1e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.82e-06	4.07e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.75e-06	3.9e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.73e-06	3.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.69e-06	3.79e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.66e-06	3.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.64e-06	3.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.63e-06	3.65e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.63e-06	3.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.61e-06	3.6e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.6e-06	3.57e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.57e-06	3.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.55e-06	3.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.53e-06	3.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.5e-06	3.36e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.46e-06	3.27e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.44e-06	3.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.43e-06	3.2e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.41e-06	3.15e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.4e-06	3.13e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.4e-06	3.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.39e-06	3.11e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.28e-06	2.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.28e-06	2.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.25e-06	2.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.08e-06	2.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1e-06	2.24e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	9.63e-07	2.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.89e-07	1.99e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.43e-07	1.44e-05	CbGpPWpGaD
